Agios Pharmaceuticals
AGIO
AGIO
171 hedge funds and large institutions have $3.07B invested in Agios Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
+4
Holders Change %
+2.4%
% of All Funds
4.27%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
30
Increased
60
Reduced
54
Closed
24
Calls
$23.8M
Puts
$19.6M
Net Calls
+$4.14M
Net Calls Change
+$10.9M
Top Buyers
| 1 |
Alkeon Capital Management
New York
|
$30.5M |
| 2 |
Goldman Sachs
New York
|
$62.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$117M |
| 4 |
MWNA
Marshall Wace North America
New York
|
$16M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$32.8M |
